Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Marimed (MRMD) Non-Current Receivables (2016 - 2025)

Marimed (MRMD) has disclosed Non-Current Receivables for 11 consecutive years, with $827000.0 as the latest value for Q2 2025.

  • Quarterly Non-Current Receivables rose 39.46% to $827000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $827000.0 through Jun 2025, up 39.46% year-over-year, with the annual reading at $556000.0 for FY2024, 11.75% down from the prior year.
  • Non-Current Receivables for Q2 2025 was $827000.0 at Marimed, up from $556000.0 in the prior quarter.
  • The five-year high for Non-Current Receivables was $8.5 million in Q2 2023, with the low at $556000.0 in Q4 2024.
  • Average Non-Current Receivables over 5 years is $1.4 million, with a median of $814000.0 recorded in 2023.
  • The sharpest move saw Non-Current Receivables soared 1047.49% in 2023, then crashed 92.99% in 2024.
  • Over 5 years, Non-Current Receivables stood at $1.7 million in 2021, then crashed by 58.05% to $704000.0 in 2022, then decreased by 10.51% to $630000.0 in 2023, then decreased by 11.75% to $556000.0 in 2024, then skyrocketed by 48.74% to $827000.0 in 2025.
  • According to Business Quant data, Non-Current Receivables over the past three periods came in at $827000.0, $556000.0, and $814000.0 for Q2 2025, Q4 2024, and Q3 2024 respectively.